Form 4: GEO Group CFO Receives Restricted Stock Grant

Sentiment:

Insider Transaction


Shayn P. March, CFO of GEO Group, Inc., has been granted 12,175 shares of restricted stock, with vesting contingent on time-based and performance-based metrics.

Summary

  • Shayn P. March, Senior Vice President and Chief Financial Officer of The GEO Group, Inc., received a grant of 12,175 shares of restricted stock on April 1, 2026.
  • The grant is divided equally: 50% is time-based restricted stock, and 50% is performance-based restricted stock.
  • The time-based portion will vest in three equal annual installments over three years, starting on the anniversary of the grant date.
  • The performance-based portion's vesting is contingent upon the achievement of specific performance goals set by the company's compensation committee between January 1, 2026, and December 31, 2028.
  • These performance goals are split between return on capital employed (50%) and total shareholder return (50%).
  • Vesting for the performance-based stock also occurs in three equal annual installments over three years, provided the performance goals are met.
  • Following these transactions, March beneficially owns 41,950 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it details a standard executive compensation grant rather than significant financial performance or strategic shifts.

Positives

  • The grant of restricted stock aligns the CFO's incentives with the company's long-term performance and shareholder value.
  • The performance-based component of the award directly links executive compensation to key financial and market metrics (Return on Capital Employed and Total Shareholder Return).
  • The phased vesting schedule for both time-based and performance-based stock encourages retention and sustained performance.

Negatives

  • Vesting of a significant portion of the award (50%) is contingent on achieving specific, yet undisclosed, performance goals, introducing uncertainty.
  • The performance period for the performance-based stock (January 1, 2026, to December 31, 2028) indicates that the full benefit of this portion of the award is not immediate.

Risks

  • Failure to achieve the specified performance goals for return on capital employed or total shareholder return could result in the forfeiture of the performance-based restricted stock.
  • Market volatility and economic conditions could impact the company's ability to meet performance targets, affecting the CFO's compensation.
  • The three-year vesting schedule for both components means that a substantial portion of the award is not realized until the end of the vesting period.

Future Outlook

The future outlook for the performance-based restricted stock is contingent on the company achieving specific performance goals related to return on capital employed and total shareholder return between January 1, 2026, and December 31, 2028. Vesting will occur in tranches over three years, subject to these goals being met.

Management Comments

  • The Reporting Person received an initial grant of 12,175 shares of restricted stock on April 1, 2026, pursuant to his Executive Employment Agreement.
  • 50% of the award consists of time-based restricted stock and 50% of the award consists of performance-based restricted stock.
  • This reflects the time-based restricted stock which one-third will vest each year on the anniversary grant date over a three year period.
  • This grant of restricted stock of The GEO Group, Inc. shall vest upon the attainment of certain performance goals in accordance with the terms of the Company's equity compensation plan.
  • Vesting of the performance-based restricted stock of GEO is contingent upon the achievement by GEO of certain performance-based metrics during the period from January 1, 2026 to December 31, 2028 as certified by the compensation committee.
  • Of the grant of performance-based restricted stock, 50% is subject to vesting based on certain return on capital employed performance goals being met and 50% is subject to vesting based on GEO's total shareholder return.
  • Both portions of the restricted stock award will vest one-third each year over a three-year period to the extent the performance goals are achieved.

Industry Context

StockSavvy.ai notes that the issuance of performance-based restricted stock to key executives is a common practice in the corrections and private prison industry, aiming to align leadership incentives with operational efficiency and shareholder returns amidst evolving regulatory and political landscapes.

Stakeholder Impact

  • Shareholders: The alignment of executive incentives with company performance and shareholder returns is generally positive for shareholders, though the actual impact depends on the achievement of performance goals.
  • Employees: The grant may signal a focus on long-term strategic execution, potentially influencing employee morale and retention if the company performs well.
  • Management: The CFO's compensation is directly tied to the company's success, providing a strong incentive for effective financial management and strategic decision-making.

Next Steps

  • Vesting of time-based restricted stock will occur in one-third increments annually on the anniversary of the grant date (April 1, 2026).
  • Vesting of performance-based restricted stock will occur in one-third increments annually over three years, contingent on the achievement of specified performance goals.
  • The company's compensation committee will certify the achievement of performance goals by December 31, 2028.

Key Dates

DateDescription
01/01/2026Start of performance period for performance-based restricted stock.
04/01/2026Date of initial grant of restricted stock to Shayn P. March.
12/31/2028End of performance period for performance-based restricted stock.
04/02/2026Date the Form 4 filing was signed.

Keywords

GEO Group, Form 4, Restricted Stock, Executive Compensation, Shayn P. March, Vesting Schedule, Performance Goals, Return on Capital Employed, Total Shareholder Return, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.